scholarly journals Nursing Implications in the ECMO Patient

Author(s):  
Alex Botsch ◽  
Elizabeth Protain ◽  
Amanda R. Smith ◽  
Ryan Szilagyi
Keyword(s):  
Author(s):  
Stefano Isgrò ◽  
Francesco Mojoli ◽  
Leonello Avalli

1990 ◽  
Vol 1 (2) ◽  
pp. 348-364 ◽  
Author(s):  
Beth Kaplan McDermott ◽  
Martha A. Q. Curley

Extracorporeal membrane oxygenation (ECMO) is the process of using prolonged cardiopulmonary bypass to support patients with reversible respiratory and/or cardiac failure who are refractory to maximal conventional therapy. This process has been used extensively for critically ill neonates, with encouraging results. The use of ECMO in the pediatric population has been limited but is increasing. The history, mechanics, and current applications of ECMO are discussed in this article. Critical care nursing management of the pediatric or neonatal ECMO patient focuses on optimizing recovery of the pulmonary and/or cardiac system while preventing complications. A case study of a pediatric ECMO patient is presented which illustrates the complex nursing care issues related to use of this intervention. Future directions for ECMO are addressed


1992 ◽  
Vol 27 (4) ◽  
pp. 527-528 ◽  
Author(s):  
Edward G. Ford ◽  
James B. Atkinson

2019 ◽  
Vol 23 (3) ◽  
pp. 283-287 ◽  
Author(s):  
Asami Ito ◽  
Yoshiaki Iwashita ◽  
Ryo Esumi ◽  
Ken Sasaki ◽  
Masahiro Yukimitsu ◽  
...  

AbstractWe report two cases of acquired factor XIII deficiency with bleeding events during veno-venous extracorporeal membrane oxygenation (ECMO). Case 1: A 76-year-old man diagnosed with aspiration pneumonia after near-drowning was started on ECMO. Later, the patient presented with hemoptysis and anemia. Blood tests showed a decreased factor XIII activity of 29%. Although the patient recovered after receiving 1200 International Units of factor XIII concentrate, the patient had another episode of decreased factor XIII activity and bloody stool and was treated again with factor XIII concentrate. Case 2: A 48-year-old female diagnosed with pneumonia was started on ECMO. Soon after, she presented with hemoptysis and anemia. Blood tests showed a decreased factor XIII activity of 39%. The patient was treated with 720 IU of factor XIII concentrate with good recovery. Acquired factor XIII deficiency cannot be detected by routine coagulation tests, therefore it may be under-diagnosed in the ICU. Detection of acquired factor XIII deficiency is essential when treating a bleeding ECMO patient.


2016 ◽  
Vol 44 (12) ◽  
pp. 128-128
Author(s):  
Markos Kashiouris ◽  
Vishal Yajnik ◽  
Varun Bhasin ◽  
Michael Czekajlo ◽  
Orlando Debesa
Keyword(s):  

Author(s):  
Akram Farran ◽  
Daniel Farinas Lugo ◽  
Joseph Boyer

Genetic syndromes such as Brugada syndrome can lead to lethal ventricular arrhythmias. Cardiac Sympathetic Denervation has been shown to be effective in ameliorating refractory ventricular arrhythmias. We present a 33-year-old black female with a past medical history of Brugada syndrome with an implantable cardiac defibrillator (ICD), who presented with refractory ventricular tachycardia/atrial fibrillation leading to cardiogenic shock, requiring Extracorporeal membrane oxygenation (ECMO). The patient subsequently underwent bilateral stellate ganglion sympathetic denervation in the setting of refractory ventricular arrhythmias. We present this case report to showcase that thoracoscopic bilateral cardiac sympathetic denervation can be an effective definitive treatment option for ventricular arrhythmias refractory to medical management.


Perfusion ◽  
2018 ◽  
Vol 33 (7) ◽  
pp. 568-576 ◽  
Author(s):  
Guillaume Alinier ◽  
Ibrahim Fawzy Hassan ◽  
Abdullah Alsalemi ◽  
Mohammed Al Disi ◽  
Ali Ait Hssain ◽  
...  

Introduction/Aim: The patient’s condition and high-risk nature of extracorporeal membrane oxygenation (ECMO) therapy force clinical services to ensure clinicians are properly trained and always ready to deal effectively with critical situations. Simulation-based education (SBE), from the simplest approaches to the most immersive modalities, helps promote optimum individual and team performance. The risks of SBE are negative learning, inauthenticity in learning and over-reliance on the participants’ suspension of disbelief. This is especially relevant to ECMO SBE as circuit/patient interactions are difficult to fully simulate without confusing circuit alterations. Methods: Our efforts concentrate on making ECMO simulation easier and more realistic in order to reduce the current gap there is between SBE and real ECMO patient care. Issues to be overcome include controlling the circuit pressures, system failures, patient issues, blood colour and cost factors. Key to our developments are the hospital-university collaboration and research funding. Results: A prototype ECMO simulator has been developed that allows for realistic ECMO SBE. The system emulates the ECMO machine interface with remotely controllable pressure parameters, haemorrhaging, line chattering, air bubble noise and simulated blood colour change. Conclusion: The prototype simulator allows the simulation of common ECMO emergencies through innovative solutions that enhance the fidelity of ECMO SBE and reduce the requirement for suspension of disbelief from participants. Future developments will encompass the patient cannulation aspect.


2021 ◽  
Vol 77 (18) ◽  
pp. 2208
Author(s):  
Aaron Kunamalla ◽  
Melissa Tracy ◽  
Deborah Tabachnick ◽  
Dinesh Kalra

2016 ◽  
Vol 44 (12) ◽  
pp. 356-356
Author(s):  
Kate Dolly ◽  
Maria Madden ◽  
Ray Rector ◽  
Tina Wright ◽  
Amber Pyzik ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document